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Nanoparticle tracking analysis (NTA) has attracted great interest for application in the ﬁeld of submicron
particle characterization for biopharmaceuticals. It has the virtue of direct sample visualization and
particle-by-particle tracking, but the complexity of method development has limited its routine appli-
cability. We systematically evaluated data collection and processing parameters as well as sample
handling methods using shake-stressed protein samples. The camera shutter and gain were identiﬁed as
the key factors inﬂuencing NTA results. We also demonstrated that sample ﬁltration was necessary for
NTA analysis if there were high numbers of micron particles, whereas the choice of ﬁlter membrane was
critical for data quality. Sample dilution into corresponding formulation buffer did not affect particle size
distributions in our study. Finally, NTA analysis exhibited excellent repeatability in intraday comparison
of multiple measurements on the same sample and interday comparison on different batches of samples.
Shaking-induced protein aggregation could also be sensitively monitored by NTA. In conclusion, NTA
analysis can be used as a robust stability-indicating method for the characterization of proteinaceous
submicron particles and thereby complement other analytical methods, provided that consistent sample
handling and parametric settings are established for the speciﬁc case study.
© 2016 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.Introduction
One of the major challenges in the development and production
of biopharmaceuticals is to avoid aggregation of therapeutic pro-
teins, which can be induced by different environmental stresses,
including temperature, pH, freeze-thawing, light, shaking, metals,
and even containers and closures.1 Protein aggregation can occur
through one or more pathways, and protein aggregates canera shutter; DT, detection
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®. Published by Elsevier Inc. All ricomprise native, structurally perturbed, covalently cross-linked or
chemically modiﬁed components.2 The most important concern
about protein aggregates is related to their potential immunoge-
nicity, which has been evidenced in clinical settings and in vivo and
in vitro studies.3
Aggregates have a wide range of attributes, such as size,
morphology, protein conformation, chemical modiﬁcation, and
reversibility.4 Protein aggregates are commonly classiﬁed based on
their size, including high-molecular-weight species (dimers to
oligomers, <0.1 mm), submicron particles (0.1-1 mm), subvisible
particles (1-100 mm), and visible particles (>100 mm). Despite
recent developments regarding sizing and counting of particulate
matter, no single existing analytical techniques can cover the entire
size span of protein aggregates.4 Revisions to the United States
Pharmacopeia (USP) <788>5 and <787>6 have speciﬁed some
methods for monitoring subvisible particles >10 mm in therapeutic
formulations. USP <1787>7 further provides recommendations for
how particulates in the 2- to 10-mm size range should be counted.
However, recommendations formonitoring particles <2 mmare still
missing. Even so, the U.S. Food and Drug Administration draft
Guidance for Immunogenicity Assessment for Therapeutic Proteinsghts reserved.
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smaller size ranges (0.1-2 mm) and conduct a risk assessment of
their impact on the clinical performance,8 highlighting the fact that
little is known about the correlation of presence of protein aggre-
gates and their characteristics with an immune response.9-12
Therefore, it is of great importance to develop robust analytical
methods for characterization of submicron particles and to estab-
lish standardized tests and procedures for analysis of particles in
this size range.
Dynamic light scattering (DLS), asymmetrical ﬂow ﬁeld-ﬂow
fractionation, resonant mass measurement (RMM), and nano-
particle tracking analysis (NTA) are the most commonly used
techniques for analysis of 0.1- to 1-mm particles. Although these
techniques have fundamentally different operating principles and
exhibit advantages in different aspects, it may be fair to state that
none of them can be applied as a reference method for a routine
particle characterization. DLS is the most user-friendly technique
and can be used in a high-throughput manner, but poor resolution
and the presence of small amounts of (near)micron-sized aggre-
gates can dramatically affect the accuracy of size distribution
analysis.13 Asymmetrical ﬂow ﬁeld-ﬂow fractionation, as an
established separation technique, can be used to fractionate protein
aggregates based on their size,10,14,15 but its application is limited
because of the complexity of method development and the sub-
optimal sensitivity of the detectors.16 In addition, the peak resolu-
tion is relatively low, and protein aggregates may adhere to the
channel membrane.4 RMM uses a different principle based on the
measurement of buoyant particle mass, where the passage of a
particle through a microchannel leads to alteration of the reso-
nance frequency of the sensor.17 RMM has the ability to discrimi-
nate particles that have different densities, such as protein
aggregates and silicone oil droplets.18 The main drawbacks of this
technique are frequent blockage of the sensor channel, low-
throughput measurements, and potentially poor size accuracy for
protein aggregates and other particles with unknown density.17,19
NTA measures the hydrodynamic diameters of submicron par-
ticles based on their Brownian motions. Unlike DLS, the NTA soft-
ware is able to identify and track individual particles in a recorded
video; thus, the size and number of particles in a polydisperse
sample can be characterized in more detail.13 NTA has better peak
resolution than DLS and is in a lesser degree affected by the pres-
ence of a few large particles, whichmakes it more suitable for sizing
and counting of polydisperse submicron particles in a sample.20
Along with other analytical methods, NTA has shown applica-
bility and complementarity for characterizing protein aggregates
arising in therapeutic protein products under various stress con-
ditions.9,21-23 Recently, Kotarek et al.24 reported that the pegine-
satide multiuse vial presentation withdrawn from the market
contained signiﬁcantly higher concentrations of particles charac-
terized by NTA and ﬂow imaging microscopy, although it did not
deviate from product speciﬁcations in standard physical and
chemical testing. In addition, the multiuse vial presentation was
clearly linked to serious hypersensitivity adverse events. This
report illustrates the potential value of using NTA as a standard
stability-indicating method for formulation development and
routine quality control of therapeutic products.
The NTA technique has been evaluated for characterization of
proteinaceousparticles in several studies.13,20,25 Themaindrawbacks
of NTA are the relatively narrowconcentration range (approximately
107-109 particles/mL) and the scattering noise in solutions at high
protein concentrations; thus, sample dilution is required in some
cases. However, the particle count and dilution factormay not be in a
linear relationship which depends on the diluent used25 and the
reversibilityof aggregate formation.Hence, reproducibility in sample
handling is of critical importance for NTA result validity.To add further complexity to NTA analysis, the data quality and
resultant absolute values will depend on both instrument settings
and data processing parameters that should be appropriately
adjusted for speciﬁc particle size distribution and background
scattering of an unknown sample. Hence, an experienced investi-
gator is needed to successfully perform reproducible NTA mea-
surements.26 For the purpose of routine use in biopharmaceutical
development, the efforts should be made to assess the potential
impact of parameter settings during data collection and processing.
Recently, Zhou et al.25 investigated the effects of minimum
expected particle size, complete tracking numbers, and sample
ﬂow rate, which revealed that these parameters should be properly
optimized to obtain accurate and reproducible results. Gross et al.27
further evaluated the importance of the detector threshold, camera
level, and capture time settings for NTA analysis of monodisperse
and polydisperse polystyrene beads and the chosen capture mode
for protein samples.
In the present study, we complement the aforementioned
ﬁndings by showing how data collection and processing parame-
ters and sample handling methods affected the NTA analysis of a
monoclonal antibody (mAb) sample which was stressed by
shaking and contained a substantial amount of polydisperse sub-
visible particles. We further assessed NTA analysis on measuring
the same stressed sample repeatedly, looked at the variation on
measuring different batches of samples prepared at the same
stress condition, and assessed the applicability on monitoring the
aggregation process of the mAb under shake stress. With this
study, we aimed to broaden the existing knowledge on under-
standing how robust measurements using NTA can be imple-
mented for forced degradation studies and during routine quality
control of biopharmaceuticals.
Materials and Methods
Materials
A polystyrene bead standard with 1-mm size (PS1000) was
purchased from Duke Scientiﬁc Corporation (Palo Alto, CA). Bead
standards with 100-, 300-, and 600-nm sizes (PS100, PS300, and
PS600) were obtained fromNanoSight (Salisbury, UK). The supplied
standards were ﬁrstly prediluted with 10 mMNaCl to about 1 109
total particles/mL (measured by NTA). Monodisperse samples were
then prepared with 4-fold dilutions of prediluted bead standards
before the measurements. Bead mixtures (Table 1) were prepared
bymixing 2 or 4 prediluted bead standards to a ﬁnal 4-fold dilution
of each standard. Thus, the concentration of each bead size was
expected to be the same as their corresponding monodisperse
samples.
A humanized mAb IgG4 (S241P) was produced as described
previously and frozen at 80C.28 Before the preparation of mAb
aggregates, the thawed stock protein solutionwas buffer exchanged
into 20mM sodium acetate (pH 5.2) by using IllustraNAP 5 columns
(GE Healthcare, Buckinghamshire, UK). The protein solution was
diluted with the same buffer to a concentration of 1 mg/mL and
then ﬁltered through a 0.22-mm Millex-GP low-binding syringe-
driven ﬁlter unit (Merck Millipore, Tullagreen, Ireland). Finally,
20 mL of mAb solution was placed in a 100-mL brown glass bottle
(Aluglas, Uithoorn, Netherlands) and stressed byorbital shaking in a
KS 4000 i control incubator shaker (IKA-Werke GmbH & Co. KG,
Staufen, Germany) at 250 rpm at 40C with the glass bottle in an
upright position. The aggregation process of the mAb was moni-
tored at the time points 2, 5,12, 24, 48, 72, and 120 h. Shake-induced
mAb aggregationwas also investigated at 25C at the time points 12,
24, 72, and 120 h. The effect of sample dilution on NTA results was
examined with the same 20 mM sodium acetate (pH 5.2) buffer.
Table 1
NTA Camera Settings for Optimal Image Acquisition of Standard Beads
Sample Polystyrene Beadsa 10 mM
NaClb
Screen Ac Screen B
Shutter Gain Shutter Gain
PS100 25 vol%, 100 nm 75 vol% 700 680 - -
PS300 25 vol%, 300 nm 75 vol% 75 50 - -
PS600 25 vol%, 600 nm 75 vol% 25 10 - -
PS1000 25 vol%, 1000 nm 75 vol% 5 10 - -
Mix I 25 vol%, 100 nm
25 vol%, 300 nm
50 vol% 700 680 185 50
Mix II 25 vol%, 100 nm
5 vol%, 300 nm
70 vol% 700 680 185 50
Mix III 25 vol%, 300 nm
25 vol%, 600 nm
50 vol% 75 50 25 10
Mix IV 25 vol%, 600 nm
25 vol%, 1000 nm
50 vol% 25 10 5 10
Mix V 25 vol%, 100 nm
25 vol%, 300 nm
25 vol%, 600 nm
25 vol%, 1000 nm
0 vol% 75 50 5 10
a The volume percent (vol%) of prediluted polystyrene beads.
b The volume percent (vol%) of 10 mM NaCl.
c The “single shutter and gain mode” was used to capture the videos for mono-
disperse samples (PS100, PS300, PS600, PS1000). The “extended dynamic range
mode”, which splits the capture video into 2 videos with independent shutter and
gain settings, was used to capture the videos for polydisperse samples (Mix I, Mix II,
Mix III, Mix IV, Mix V).
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A NanoSight LM20 (NanoSight, Salisbury, UK) was used for NTA
measurements. The instrument was equipped with a sample
chamber with a 642-nm laser and a Viton ﬂuoroelastomer O-ring.
The standards and protein samples were injected in the sample
chamber with 1-mL sterile BD Plastipak syringes (Becton Dickinson
S.A., Madrid, Spain) until the liquid reached the tip of the nozzle.
The sample chamber was visually checked to avoid the introduction
of air bubbles. According to the NanoSight syringe pump operating
manual, an external syringe pump with a relatively slow ﬂow rate
(15 arbitrary units) was used to advance the sample during the
measurement. This ﬂow rate is also close to the value recom-
mended by Krueger et al.,29 which (compared to no sample ﬂow)
increases the measured sample volume while maintaining appro-
priate particle peak distinction. The software NTA 2.3 was used for
video capture and data analysis. The camera settings were manu-
ally adjusted, and the recorded videos were processed with a vis-
cosity setting of 0.95 cP at the measured temperature. The
monodisperse polystyrene beads were measured in “single shutter
and gain mode” (Table 1) to ﬁnd the optimal settings for each
particle size distribution. The bead mixtures and protein samples
weremeasured in “extended dynamic range (EDR) mode” (Table 1),
where 2 videos with different camera settings are captured in an
interleaved sequence to allow optimal capture of both small and
large particles in polydisperse samples. A mAb sample stressed by
orbital shaking at 40C for 72 h was used as a model protein sample
for the assessment of data collection and processing parameters.
Three measurements for each sample were performed. The NTA
graphs display the size distribution with the error bars obtained by
the standard deviation at each data point. The total concentration
of submicron particles was calculated by summation of the con-
centrations at the size range of 101-1000 nm.
Microﬂow Imaging (MFI)
The stressed mAb samples were additionally analyzed by a
MFI5200 particle analyzer (ProteinSimple, Ottawa, Ontario,
Canada) equipped with a 100-mm silane-coated ﬂow cell. The MFIView System Software version 2-R3.1.0.31.3097 was used to con-
trol the instrument. The ﬂow cell cleanliness was checked between
measurements. The illumination was optimized before each
measurement using the protein formulation buffer. Sample vol-
umes of 340 mL with a prerun volume of 200 mL were analyzed at a
ﬂow rate of 0.17 mL/min. Samples with a total particle concen-
tration above 1  106 particles/mL were diluted with the formu-
lation buffer and reanalyzed immediately after sample dilution.
Three measurements for each sample were performed, and the
mean and standard deviations were calculated. An in-house
developed software30 was used for data analysis.
Size-Exclusion High-Performance Liquid Chromatography
The stressed mAb samples were centrifuged at 12,000 rpm for
15 min in a 1-15 centrifuge (Sigma, Osterode am Harz, Germany)
and then measured by size-exclusion high performance liquid
chromatography (SE-HPLC) on an Agilent 1200 (Agilent Technolo-
gies, Waldbronn, Germany) system using a TSKgel G4000SWxl
column (Tosoh Corporation, Tokyo, Japan). Twenty microliter of
each sample was injected. The mobile phase consisted of 100 mM
sodium phosphate and 100 mM sodium sulfate (pH 7.2), and the
ﬂow rate was 0.35 mL/min. The ultraviolet (UV) absorbance peaks
were detected at 280 nm.
UV Spectroscopy
The turbidity of stressed sample was measured as the absor-
bance value at 350 nm (A350)31 using an Inﬁnite M1000microplate
reader (Tecan Austria GmbH, Grodig, Austria). A 96-well UV-Star
UV-transparent microplate (Greiner Bio-One GmbH, Frick-
enhausen, Germany) was ﬁlled with 200 mL of protein solution.
Duplicate measurements were performed for each sample, and the
UV absorption from buffer solution was subtracted.
Results and Discussion
NTA Analysis of Bead Standards for Assessment of Accuracy and
Precision
The light scattering signal of a given particle depends on its size
and refractive index; thus, the camera setting for a monodisperse
sample of polystyrene beads can be optimized by adjusting the
camera shutter (CS) and camera gain (CG), deﬁning the time the CS
is open and the light sensitivity of the camera, respectively. A basic
principle is that an illuminated particle should be seen as a clear
light spot with a recognizable center but devoid of saturation of
scattering, which is important for tracking the particles in a precise
way. As provided in Table 1, the optimal camera settings for the 4
monodisperse samples (100, 300, 600, 100 nm) ranged from 700 to
5 for CS and 680 to 10 for CG. The measured size distribution of
particles in each sample exhibited a resolvable peak with the
expected size (main peak maximum; Fig. 1).
The data collection of a mixture of bead standards was more
challenging because particles with different sizes could not be
measured optimally at the same time when using a single camera
setting. In the NTA 2.3 software, however, an EDRmode can be used
to record the interleaved video streams on 2 screens with different
parameters, as long as the 2 shutter settings are above or below 180
in concert, otherwise a camera conﬁguration conﬂict will occur.
Therefore, for dual-disperse bead mixtures, the smaller particles
could be tracked on screen A with its optimal camera setting and
the larger particles on screen B (Table 1). As shown in Figures 1a-1c,
the peaks for bead standards of 300, 600, and 1000 nm were still
resolvable in all 3 dual-disperse samples. However, when mixing
Figure 1. NTA analysis of bead standards (a-d). The samples were measured using the camera settings described in Table 1. The collected data for all the samples were processed
using the same parameters.
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diluted stock suspension (Mix I), the 100-nm bead standard was
hardly detectable (Fig. 1a). As 300-nm beads exhibit a much
stronger light scattering signal than 100-nm beads at the same CS
and CG, the large glaring particles from the 300-nm beads could
maskmost of the small particles. This was certiﬁed by reducing 80%
of the added 300-nm bead standard (Mix II), after which the 100-
nm bead standard could be correctly sized (peak maxima), while
the particle concentration of each contributing species was less
well characterized (Fig. 1a, Table 2). The observations described
previously are in accord with the results reported by Krueger
et al.,29 where a clear bias toward the larger species was found with
all tested ratios of 100- and 200-nm bead mixtures.
The tetradisperse sample (Table 1, Mix V) contained all 4 sizes of
bead standards. Because of the high concentration of total particles,
Mix V was diluted in 10 mM NaCl by a factor of 4 during theTable 2
Measured and Expected Standard Bead Particle Concentrations (E8 Particles/mL) in NTA
Sample Size Range 51-200 nm 201-400 nm
Mix I Measured 0.84 ± 0.02 2.86 ± 0.04
Expected 2.43 ± 0.08 2.17 ± 0.22
Mix II Measured 1.74 ± 0.02 1.02 ± 0.04
Expected 2.28 ± 0.09 0.69 ± 0.05
Mix III Measured 0.64 ± 0.03 1.44 ± 0.07
Expected 0.25 ± 0.03 2.04 ± 0.17
Mix IV Measured 0.28 ± 0.03 0.57 ± 0.03
Expected 0.10 ± 0.01 0.29 ± 0.04
Mix V Measured 0.68 ± 0.04 2.65 ± 0.08
Expected 2.53 ± 0.09 2.46 ± 0.18
The size ranges corresponding to the speciﬁed size of added bead standards are highlighte
concentrations are printed in italic. The expected particle concentrations were calculate
samples at each size range.measurement. The 1000-nm bead standard showed very strong
light scattering when using the camera setting for the 100-nm bead
standard, and most of the smaller particles were masked by glaring
light during the measurement (data not shown). In consequence,
NTA analysis was performed using the optimal camera setting for
300-nm beads on screen A and the setting for 1000-nm beads on
screen B. This example illustrates the kind of operator choices that
will have a huge effect on data interpretation and results. Figure 1d
shows the particle size distribution for the tetradisperse sample
after 4-foldmultiplication of the raw data. The 3 peaks representing
300-, 600-, and 1000-nm beads were clearly resolved, whereas
100-nm beads could not be detected because of the lower settings
on CS and CG.
To further assess the accuracy and precision of NTA, the particle
concentrations at different size ranges and the total particle con-
centrations were calculated from the NTA results of the beadfor Different Size Ranges
401-800 nm 801-1200 nm 51-1500 nm
0.24 ± 0.03 0.02 ± 0.00 3.96 ± 0.06
0.18 ± 0.02 0.01 ± 0.00 4.80 ± 0.28
0.10 ± 0.01 0.01 ± 0.00 2.87 ± 0.07
0.05 ± 0.01 0.00 ± 0.00 3.02 ± 0.09
1.93 ± 0.13 0.14 ± 0.01 4.17 ± 0.16
1.61 ± 0.11 0.09 ± 0.01 4.00 ± 0.19
1.69 ± 0.08 1.42 ± 0.09 4.09 ± 0.22
1.90 ± 0.18 1.03 ± 0.11 3.46 ± 0.20
2.62 ± 0.12 2.00 ± 0.19 8.21 ± 0.38
2.09 ± 0.16 1.03 ± 0.11 8.26 ± 0.18
d in bold. The values with a large deviation betweenmeasured and expected particle
d by summation of the particle concentrations of the corresponding monodisperse
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on the NTA results of the monodisperse samples. As provided in
Table 2, the total particle concentrations at the full size range
(51-1500 nm) for all the bead mixtures have <20% deviation in
comparison with their expected concentrations. However, this was
not always the case for the subsets of size distributions. For Mix II,
Mix III, and Mix IV, the measured particle concentrations matched
the expected ones quitewell in each size range.Mix I andMix V also
showed a good match in the range of 201-1200 nm, whereas the
measured particle concentrations in the range of 51-200 nm were
much lower than expected. As discussed above, the 100-nm bead
standard in a bead mixture could be either masked by glaring light
from larger particles when using a higher camera setting (Mix I) or
become invisible due to weak scattering when using a lower
camera setting (Mix V). Thus, the sensitivity of NTA analysis could
be signiﬁcantly compromised for particles <200 nm in the presence
of (much) larger ones. This might be the main drawback of NTA
when measuring polydisperse samples. Protein aggregates are
generally highly heterogeneous with particle sizes ranging from a
few nanometers to a few millimeters, and in the following para-
graphs, we will discuss how submicron protein aggregates in a
shake-stressed mAb sample can be characterized by NTA.
NTA Analysis of Protein Aggregates: Sample Handling, Data
Collection, and Data Processing
To generate a substantial amount of protein aggregates, an IgG4
mAb was stressed by orbital shaking at 40C for 72 h. MFI analysis
and visual inspection demonstrated that the stressed sample con-
tained both micron particles (1.7  107 particles/mL) and visible
particles, necessitating the removal of those large aggregates before
NTA analysis. In this study, 3 commercially available ﬁlter units,
including 5-mm Millex-SV hydrophilic polyvinylidene diﬂuoride
(PVDF) syringe ﬁlter (Merck Millipore, Tullagreen, Ireland), 1.2-mm
Puradisc FP 30 cellulose acetate syringe ﬁlter (GE Healthcare,
Buckinghamshire, UK), and 0.22-mm Millex-GP hydrophilic poly-
ethersulfone syringe ﬁlter (Merck Millipore, Tullagreen, Ireland),
were tested for sample ﬁltration. Twomilliliter of stressedmAbwas
ﬁltered through each type of syringe ﬁlter and then measured by
NTA in EDR mode (CS A: 700, CS B: 700; CG A: 680, CG B: 50). The
nonﬁltered sample had large glaring particles dominating screen A,
and the smaller particles were seriouslymasked.When plotting the
relative light scattering intensity (also called peak intensity, the
sum of all pixel values within a particle image) against particle size
(Fig. 2b), a large number of particles with high scattering intensity
were observed at the full size range of the nonﬁltered sample.
Smaller particles are expected to have lower scattering intensity
than larger particles of similar composition; thus, the sources ofFigure 2. (a) The effects of sample ﬁltration onNTA analysis of shake-stressed IgG4mAb. Two
scattering intensity plotted against particle size. (c) The dilution effects of protein sample on N
concentrations were multiplied by dilution factors. Data collection: EDR mode, CS A: 700, CSnoise are the ﬂares of the large glaring particles identiﬁed from the
video images, and the size distribution proﬁle of nonﬁltered sample
(Fig. 2a) presented mostly artifacts especially in the lower size
range. However, this was not the case in a recent report by Krueger
et al.,29 in which the determined particle concentrations between
ﬁltered and unﬁltered samples were not signiﬁcantly different. This
discrepancy may be related to differences in aggregation proﬁle
and instrument settings.
Filtration of the sample through the 5-mm syringe ﬁlter could
signiﬁcantly improve the measurement and remove the most
unwanted noise caused by large glaring particles (Fig. 2a). The size
distribution presented a bell-shape proﬁle as normally seen in
other studies.13,20,25 As discussed previously, NTA analysis of a
polydisperse sample could compromise the sensitivity for smaller
particles, and the number of protein aggregates with sizes <200 nm
might be underestimated or completely undetected. After ﬁltration
of the samples through 1.2- and 0.22-mm syringe ﬁlters, hardly any
submicron particles were detected (Fig. 2a). Further ﬁltration tests
on nonstressed mAbs revealed 4.9% and 9.8% protein loss, respec-
tively, which is likely a result of protein adsorption to the mem-
brane (Supplementary Table 1). Therefore, similarly, one would
expect some level of adherence of particles to the membrane dur-
ing the ﬁltration. Although less protein loss (1.9%) was observed in a
nonstressed sample after 5-mm ﬁltration, the mentioned observa-
tions would imply that submicron particles might also be partially
removed, and the measured concentration may not accurately
reﬂect the real submicron particle concentration in the nonﬁltered
sample. It has to be emphasized that the syringe ﬁlters used in our
study differ both in their pore sizes and membrane characteristics.
In addition, the intact protein and protein aggregates may differ in
their exposed surface hydrophobicity. Thus, the ﬁltration tests on
nonstressed mAbs may not be fully predictive for the amount of
particle loss upon ﬁltration. Altogether, ﬁltration should be used in
comparative studies if the nature of the sample (i.e., presence of
large amounts of micron particles) requires it in the realization that
some of the submicron particles could be lost even when using
micron-sized pore ﬁlters. However, if ﬁltration is not included in
sample handling for these samples, the samples might not be
applicable for NTA analysis.
Another important sample handling procedure before NTA
analysis is the implementation of sample dilutionwhen the particle
concentration is >109 particles/mL. At more than 109 particles/mL,
the close proximity of particles can make it impossible for the
software to perform the so-called point tracking. Zhou et al.25 have
previously observed that a linear relationship between particle
count and dilution factor depended on the protein concentration of
the diluent. We assessed 2 dilution factors (2- and 5-fold) using
protein-free diluent for the stressed mAb (ﬁltered through 5-mmmilliliter of stressed samplewas ﬁltered through each syringe ﬁlter. (b) The relative light
TA analysis. The sample was ﬁltered through a 5-mmPVDF syringe ﬁlter, and the particle
B: 700, CG A: 680, CG B: 50. Data processing: DT 10, Blur 7  7, MTL 10, MEPS 50 nm.
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proﬁles did not exhibit signiﬁcant differences from the nondiluted
sample (Fig. 2c). The relative standard deviation of the total particle
concentrations of the 3 samples within the size range of 101 to
1000 nm was only 8.4% (Supplementary Table 2). The nature of
protein aggregates is relevant for their stability upon sample dilu-
tion. That we observe a linear relationship using a protein-free
diluent could reﬂect differences in the nature of the aggregates
compared to the study by Zhou et al.25 or the minimal time delay
between sample dilution and sample analysis used in the present
study. Larger dilution factors were not assessed in this study
because the particle concentration would be too low for standard
NTA analysis, and the measurement time would have to be
extended to get adequate statistics.
Whenworking with polydisperse protein aggregates, CS and CG
should be appropriately deﬁned during data collection. As shown in
Figure 3, the camera settings were assessed in both normal mode
and EDRmode. It is obvious that the increase of CS and CG at normal
mode could signiﬁcantly alter the size distribution (Figs. 3a and 3b).
A similar conclusion was also drawn by Gross et al.27 in a recent
report. The relative standard deviations of the total particle con-
centrations were >50% (Supplementary Table 3). In EDR mode, CS
and CG on screen A were set to the highest level (700 and 680,
respectively) to increase the sensitivity for smaller submicron
particles leaving only the camera settings on screen B to be
assessed. Interestingly, the measured size distribution and total
particle concentration did not seem to alter on the changes assessed
in the present study (Fig. 3c and Supplementary Table 3), whereas
the noise level at the size range of 0-200 nm (small particle artifacts
derived from around or within a particle image or “blob” and
identiﬁed by their unusual high relative scattering intensities) was
reduced compared to the normal mode of data collection.
To further minimize the aforementioned noise level, the data
processing parameters should also be optimized. TheseFigure 3. The effect of data collection and processing parameters on size distribution and p
the same mAb sample stressed by orbital shaking at 40C for 72 h and ﬁltered through 5-mm
gains (b). In EDR mode, the data were collected with the highest camera settings on screen A
B1 was used to assess data processing parameters (d-f), where the individual parameter was
50), for example varying the blur with DT 10, MTL 10, and MEPS 50.parameters include detection threshold (DT), blur, minimum
track length (MTL), and minimum expected particle size (MEPS).
DT directly alters the sensitivity to the gray-scale values on an
image. As demonstrated by Gross et al.,27 changes of DT can lead
to high variability in the results. In our study, the NTA data of the
stressed samples were processed using a constant DT value of 10,
which helped reduce the noise level but still keep most of the
particles detected. The blur function integrates the intensities of
the pixels over a matrix and increases smoothing eliminating
unwanted noisy pixels. However, in our study, it did not seem to
improve the result (Fig. 3d and Supplementary Table 3). Krueger
et al.29 also concluded that increasing the blur parameter had
only little effect on the particle size distribution and the particle
concentration. MTL determines the minimal moving distance (the
steps taken) of a tracked particle. In principle, the sizing and
counting results can be more accurate when using more tracking
steps, but for small particles, an increased MTL might result in
underrepresentation because their rapid Brownian motion will
tend to move them out of the effective scattering volume of the
laser beam. As shown in Figure 3e, a higher MTL results in a
decrease of noise level and also in the appearance of a shoulder
on the curve. The shoulder could be the result of more accurate
sizing, whereas the total concentrations of particles were unaf-
fected (Supplementary Table 3). MEPS limits the maximum jump
distance of a particle between frames and sets an exclusion zone
of the same particle to avoid joining tracks of 2 different particles,
that is, the information from both particles can be excluded if 2
particles have overlapping exclusion zones. As shown in Figure 3f,
the left border of size distribution shifted to larger size with the
increase of MEPS value, which indicates that the particles at the
size range below MEPS setting could move out of the deﬁned
search area, thus not be effectively tracked. In addition, multiple
scattering centers of a large particle are normally close to each
other, and the larger exclusion zone could be expected to helparticle concentration for shake-stressed IgG4 mAb. All parameters were assessed using
PVDF syringe ﬁlter. In normal mode, the data were collected at different shutters (a) and
(CS 700, CG 680) but different settings on screen B (c). The data collected in EDR mode
assessed with constant settings for other parameters (DT 10, Blur 7  7, MTL 10, MEPS
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hand, a lower MEPS value could also lead to slight underesti-
mation of the particle concentrations because of the larger
exclusion zone (Fig. 3f and Supplementary Table 3). Krueger
et al.29 investigated an even lower MEPS value leading to dras-
tically reduced particle concentrations and a peak artifact on the
left side of the distribution.
In the following experiments, the mAb samples were ﬁltered
through a 5-mm syringe ﬁlter before NTA analyses. Data collection
was performed in EDR mode with CS A: 700, CG A: 680, CS B: 700,
CG B: 50. Data processing was performed using the following ﬁxed
parameters to get repeatable results: DT 10, blur 7  7, MTL 10, and
MEPS 50.Stability of Submicron Particles and Repeatability of NTA Analysis
Nonnative protein aggregation is commonly perceived as a
dynamic process in which the addition of monomers to preexisting
aggregates and/or rearrangement of preexisting aggregates lead to
the growth of irreversible aggregates.32,33 Equilibrium may also
exist between smaller and larger aggregates on static storage of
stressed samples. It has also been reported that visible and sub-
visible particles generated by shake stress could be reversible and
may dissociate into smaller aggregates over time.34 Thus, the
repeatability of NTA analysis depends on not only the consistent
parametric settings but also the way we handle the samples. In the
present study, the stability of submicron particles in our shake-
stressed mAb samples was assessed at different storage condi-
tions that are relevant for NTA analysis:
(I) Several aliquots of nonﬁltered sample were stored at room
temperature and measured over time (ﬁltered through 5-mm
PVDF syringe ﬁlters before the measurements). As shown in
Figure 4a and Supplementary Table 4, the size distribution
proﬁles and total particle concentrations did not change
considerably on static storage even after 6 h.
(II) The sample was ﬁltered through a 5-mm PVDF syringe ﬁlter
before being distributed into small aliquots. As shown in
Figure 4b, the submicron particles were as stable as in non-
ﬁltered samples, and no signiﬁcant changes were observed
on their size distributions on static storage up until at least
6 h at room temperature.
(III) The samples were frozen at 80C for 24 h. NTA results
revealed that freeze-thawing generated more submicron
particles especially when the sample was thawed at 4C
overnight (Fig. 4c and Supplementary Table 4).Figure 4. The repeatability of NTA analysis of submicron particles in stored shake-stressed Ig
5-mm PVDF syringe ﬁlter before the measurement at each time point (a). The samples were
measurement at each time point (b). The freshly prepared samples were frozen atd80C for
Data collection: EDR mode, CS A 700, CS B 700, CG A 680, CG B 50. Data processing: DT 10Overall, the samples freshly prepared by shake stress in our
study could be stored at room temperature for a couple of hours
before NTA analysis without resulting in changes in measured
particle distributions. However, freeze-thawing of stressed samples
should be avoided because it may bias the results toward larger
particles and higher particle concentrations. As mentioned with
regard to sample dilution, the storage stability of the present
sample in NTA analysis might not be representative for all protein
samples but rather a result of the formulation and/or speciﬁc type
and reversibility state of the aggregates involved.
Batch Variations and Repeatability of NTA Analysis in Sample
Preparation
Samples prepared under stress conditions can vary from batch
to batch. Consistency in particle size distribution and total con-
centration of particles generated at the same condition is crucial
for formulation screening and the selection of lead biopharma-
ceutical candidates from forced degradation studies. In our study,
3 batches of samples were prepared at the same stress conditions
but on different days. The prepared shake-stressed samples were
either analyzed on different days immediately after application
of stress or frozen at 80C and then on the same day thawed
(at room temperature for 2 h) and analyzed. As shown in Figure 5
and Supplementary Table 5, the size distribution and total con-
centration of submicron particles were similar for the 3 batches of
samples based on NTA results. The result of freshly analyzed
samples showed a bit more variation than the freeze-thawed
samples, which may arise from the variations of NTA analyses
on different days. However, freeze-thawing of stressed samples
did slightly increase the total submicron particle concentration
compared to freshly prepared samples (Supplementary Table 5).
Thus, in general, a comparative study along with consistent sam-
ple preparation and handling process should be performed to
judge if stressed samples can be frozen before analysis in case the
samples cannot be measured immediately.
Case Study: Applicability and Complementarity of NTA on
Monitoring Protein Aggregation Under Shake Stress
Characterization of submicron particles could support formu-
lation development, for example, with respect to monitoring
aggregation in forced degradation studies. Here, we further
assessed the applicability and complementarity of NTA on moni-
toring protein aggregation under shake stress at different tem-
peratures for 5 days. Three other analytical methods, that is, UVG4 mAb samples. The samples were stored at room temperature and ﬁltered through a
ﬁltered through a 5-mm PVDF syringe ﬁlter and stored at room temperature until the
24 h and then thawed at either 4C or room temperature before the measurements (c).
, Blur 7  7, MTL 10, MEPS 50 nm.
Figure 5. Repeatability of the sample preparation. Three batches of shake-stressed IgG4 mAb samples were prepared at the same stress conditions. The freshly prepared samples
were measured on different days (a). The freeze-thawed stressed samples were measured on the same day (b). Data collection: EDR mode, CS A 700, CS B 700, CG A 680, CG B 50.
Data processing: DT 10, Blur 7  7, MTL 10, MEPS 50 nm.
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tion. Error bars for the replicates are included in Figures 6 and 7
with the exception of SE-HPLC data; however, some of them are
contained within the symbols. As shown in Figures 6a and 6d, the
micron-sized particles characterized by MFI continued to grow at
both 40C and 25C within the period investigated. It is obvious
that, under shake stress, the micron particles formed much faster
at higher temperature. NTA analysis revealed that submicron
particles also formed over time under shake stress (Figs. 6b andFigure 6. Agitation-induced subvisible particle formation of shake-stressed IgG4 mAb. The
submicron particles were measured by MFI (a, d) and NTA (b, e), respectively. In addition, th6e) and that a similar temperature-dependent process was
observed. SE-HPLC analysis further demonstrated a loss of
monomer content (Figs. 6c, 6f, and 7d), which was in accordance
with the time course of particle formation (Figs. 7b and 7c).
However, there was no substantial increase in oligomers detected
though the monomer loss was almost 40% after shake stress at
40C for 120 h (Fig. 6f). The turbidity of the samples was measured
as an optical density at 350 nm, which can be used as a rough
measure for the overall formation of protein aggregates andsamples were stressed by orbital shaking at 25C (a-c) and 40C (d-f). The micron and
e monomer loss and the formation of oligomers were characterized by SE-HPLC (c, f).
Figure 7. Application of complementary methods for monitoring IgG4 mAb aggregation induced by shake stress at either 25C or 40C. Turbidity of the protein solutions was
measured as optical density values at 350 nm (a). Total concentration of micron particles was characterized byMFI (b). Total concentration of submicron particles was characterized by
NTA (c). Monomer loss of stressed samples (d) was calculated based on the area of monomer peak in the SE-HPLC proﬁle of each sample compared to that of the nonstressed sample.
X. Tian et al. / Journal of Pharmaceutical Sciences 105 (2016) 3366-33753374particles. Figure 7 shows that the turbidity results were consistent
with the development in particle concentrations characterized by
MFI and NTA.
Summary
The polydispersity of protein aggregates poses a challenge for
NTA analysis. Size and refractive index of the particles in suspen-
sion can dramatically affect the extent of light scattering, the
smaller particles may be masked by the glaring light from larger
particles, and the glaring effect can falsely be interpreted as unique
particles. Therefore, samples containing substantial numbers of
micron particles should be appropriately handled to allow NTA
analysis. The most convenient way to remove the large particles is
ﬁltration; however, there is only a limited number of available
ﬁlters with different molecular weight cutoff values. In addition,
particles smaller than the pore size may adhere to the ﬁlter,
resulting in underestimated particle concentrations. In the present
study, a 5-mm PVDF membrane was chosen as the best compromise
for ﬁltration, resulting in a minimal loss of submicron aggregates
and adequate removal of micron-sized aggregates. Centrifugation
might be an alternative for sample handling and potentially could
fractionate the particles with higher resolution than ﬁltration.
During data collection and processing, different types of pro-
tein aggregates have to be characterized by using a single para-
metric setting at the same time. Although the EDR mode allows 2
different camera settings, sizing and counting of the particles in a
broad size range (100-1000 nm) remain very challenging. NTA
analysis of polydisperse bead standards revealed that we have to
limit the camera sensitivity when there are substantial numbers of
larger particles; thus, the detection of smaller particles (<200 nm)might be compromised in this case (Fig. 1d). This is likely to
happen when protein aggregates are measured. The NTA proﬁle of
stressed protein samples often exhibits a bell-shape peak at about
200 nm size (Figs. 6b and 6e), which may not reﬂect the real size
distribution especially for smaller particles but rather results from
the resolution cutoff of the method when applied to complex
polydisperse protein samples. Nevertheless, as shown in our case
study, NTA can provide valuable information by monitoring the
formation of submicron particles, allowing us to compare different
samples, provided that consistent parametric settings are used
during data collection and processing. Importantly, these param-
eters should be carefully optimized, and it is deﬁnitely beneﬁcial
to use the EDR mode when characterizing heterogeneous pro-
teinaceous particles.
The repeatability of NTA analysis is also crucial for formulation
development and quality control in pharmaceutical industries,
which depends not only onwell-developed analytical protocols but
also on the stability of the protein aggregates under investigation.
When there are a lot of samples or when a sample cannot be
measured immediately, an acceptable delay time between sample
preparation and NTA analysis and appropriate sample storage
conditions have to be considered. In addition, the effect of dilution
on particle stability needs to be evaluated when the particle con-
centration exceeds the upper concentration limit of the instrument.
In the present study, the submicron particles of an IgG4 mAb
generated by shake stress exhibited a satisfactory stability using
low factor dilution (Fig. 2c) and storage at room temperature (Figs.
4a and 4b). Although freeze-thawing altered the size distribution
and total concentration of particles to some extent (Fig. 4c), the NTA
results were still repeatable if the samples were prepared and
treated in the same way. When monitoring protein aggregation
X. Tian et al. / Journal of Pharmaceutical Sciences 105 (2016) 3366-3375 3375under shake stress, NTA could sensitively detect the formation of
submicron particles at early time points (Figs. 6b and 6e). In addi-
tion, the aggregation kinetics characterized by NTA was in quali-
tative agreement with the results of the other analytical methods.
Altogether, NTA is a powerful and robust technique for submi-
cron particle characterization, which strongly complements other
analytical methods. However, it has to be mentioned that the par-
ticle stability may vary among different proteins and stress condi-
tions. Therefore, a tailored stability-indicating method, including
an evaluation of effects of sample preparation and storage on par-
ticle stability, needs to be developed when studying the (forced)
degradation of different biopharmaceutical candidates.Acknowledgments
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